NCT06244056

Stellate Ganglion Block as Novel Treatment for Heart Failure Patients

• Status: Unknown
• Phase: Phase 2 / Phase 3
• Study type: Interventional
• Enrollment: 108 (estimated)
• Sponsor: Mina sobhi said fam · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

Stellate Ganglion Block as Novel Treatment for Heart Failure Patients

Detailed description

Stellate Ganglion Block as Novel Treatment for Heart Failure Patients

Conditions

• Stellate Ganglion Block

Interventions

Type	Name	Description
PROCEDURE	Stellate Ganglion Block	A stellate ganglion block is performed by a medical professional in a sterile setting. Firstly Position of patient: Semi-lateral decubitus position, with the neck turned contralateral. Using Probe of ultrasound: Linear 6-13 MHz to guide the needle to the stellate ganglion , The skin at the injection site is cleaned with an antiseptic solution to reduce the risk of infection. A local anesthetic is injected into the skin and deeper tissues to numb the area. Needle:25G 1.5 inch or 22G 3.5 inch is inserted through the skin and deeper tissues until it reaches the stellate ganglion.Once the needle is in the correct position, 3-5 mL of local anesthetic (0.25-0.5% bupivacaine) The procedure typically takes about 15-20 minutes.

Timeline

• Start date: 2024-02-05
• Primary completion: 2025-01-01
• Completion: 2025-01-01
• First posted: 2024-02-06
• Last updated: 2024-02-06

Locations

2 sites across 1 country: Egypt

Regulatory

• FDA-regulated drug study